Kelly Thomas Patrick — SEC Form 4 filings
SEC reporting owner CIK 1410514. 4 Form 4 filings on record with FilingPulse; latest filed 2025-10-17.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-01-18 to 2025-10-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 5,445 shares, $82,243 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 3,010 shares @ $15.62 ($47,009) in Deciphera Pharmaceuticals, Inc., filed 2024-02-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | 3 | — | 2 legs · 5,445 sh · $82,243 | 12 |
| Xenon Pharmaceuticals Inc. (XENE) | Chief Financial Officer | 1 | — | — | 2 |
Form 4 filings — Kelly Thomas Patrick
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-17 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 225,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Deciphera Pharmaceuticals, Inc. | Grant/award (A): 34,157 · Disposition to issuer (D): 72,029 · Code (U): 42,478 · Disposition to issuer (D): 85,456 (derivative) · Disposition to issuer (D): 5,650 (derivative) · Disposition to issuer (D): 103,219 (derivative) · +4 more | EDGAR |
| 2024-02-20 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 17,275 @ $0 · Sale (S): 3,010 @ $15.62 · Grant/award (A): 69,100 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Sale (S): 2,435 @ $14.47 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1410514 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →